2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial (Q84502143)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 June 2012

Language	Label	Description	Also known as
English	2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial	scientific article published on 28 June 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22748821%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22748821%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

ChEBI release 2020-05-28

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

Maximilian von Eynatten

6

object named as

Maximilian von Eynatten

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22748821%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Baptist Gallwitz

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22748821%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Julio Rosenstock

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22748821%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Thomas Rauch

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22748821%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sudipta Bhattacharya

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22748821%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sanjay Patel

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22748821%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Klaus A Dugi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22748821%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Hans-Juergen Woerle

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22748821%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

0 references

publication date

28 June 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22748821%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22748821%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

380

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22748821%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

475-483

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22748821%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

9840

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22748821%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential roles of erythropoietin in the management of anaemia and other complications diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality?: a meta-analysis of observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypoglycaemia in Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antidiabetic oral treatment in older people: does frailty matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes and obesity: the twin epidemics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular effects of DPP-4 inhibition: beyond GLP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing the cardio-cerebrovascular safety of vildagliptin: meta-analysis of adjudicated events from a large Phase III type 2 diabetes population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960691-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(12)60691-6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22748821%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22748821%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84502143&oldid=1754701280"